1. Introduction {#sec1}
===============

Medical genetics studies the variations of human inheritance when they are the origin of an abnormal conditions or disease. Such conditions can be often diagnosed at a gross scale by means of cytogenetic analysis. In Ecuador, this analytical discipline became better known by the early 90\'s when Varas (1990) showed the existence of a 0.25% of individuals with chromosomal alterations among 12,112 newborns in Quito \[[@B1]\]. Around the globe, the statistics show that the incidence of diseases with a genetic origin that becomes evident before the age of 25 is 53/1,000 \[[@B2]\]. Many factors can have a negative influence on an embryo\'s survival; however, chromosomal aberrations are among the most significant since they alter the expression of many genes in the earlier stages of development \[[@B3]\]. Some authors suggest that the prevalence of chromosome disorders at birth is higher in developing countries possibly due to the lack of family planning services and unavailability of prenatal among other reasons \[[@B4]\]. In fact, South America bears unique characteristics that may also influence the development of diseases as a result of gene-environment interaction, characteristics such as ethnic diversity, structure and geographic location of populations, and a high frequency of exposure to environmental factors \[[@B5]\]. In the 1980s in Latin America and the Caribbean, the proportion of infant deaths attributable to congenital anomalies varied from approximately 2 to 27 per cent and ranked among the five leading causes of infant deaths in that region \[[@B6]\]. Since then, the study of the epidemiology of genetic disorders and congenital malformations is a high priority \[[@B3]\]. In 2010, National Institute of Statistics and Census (INEC) reported that congenital malformations and chromosomal anomalies in Ecuador occupy the twenty second (1.1%) among the general causes of mortality in the Ecuadorian population \[[@B7]\]. Meanwhile, the ECLAMC report unveils that there are high frequencies of anotia/microtia and harelip among the major malformations diagnosed in Ecuadorian hospitals \[[@B5]\], likely related to high altitude. The present work shows information on chromosomal alterations and variants found during 13 years of cytogenetic services provided to Ecuadorian patients referred from various hospitals around the country.

2. Materials and Methods {#sec2}
========================

A total of 2,636 individuals have been analyzed during the past 13 years. The corresponding karyotypes have been observed by the G-banding technique during the period of 1998--2012. The individuals come from many places around Ecuador and have been referred to the Institute by primary care centers in order to obtain a cytogenetic analysis. The diagnoses were classified according to the International System for Human Cytogenetic Nomenclature \[[@B8]\] and organized into three tables that show the number and percentage of cases with chromosomal autosomopathies, chromosomal gonosomopathies, and chromosomal variants and polymorphisms, respectively. The latest cases of gonosomopathies have been also analyzed by the FISH technique with the CEP X/Y DNA Probe Kit from Abbott Molecular and SRY specific primers.

3. Results {#sec3}
==========

As previously mentioned, the following tables show our findings classified in four different tables as chromosomal autosomopathies ([Table 1](#tab1){ref-type="table"}), chromosomal gonosomopathies ([Table 2](#tab2){ref-type="table"}), and translocations, chromosomal variants, and polymorphisms ([Table 3](#tab3){ref-type="table"}). It can be noted that there is an unusual high percentage of Down syndrome mosaicism and Yqh+ polymorphism.

4. Discussion {#sec4}
=============

Some of the most frequent clinic alterations that suggest the need for chromosomal analysis are mental retardation, short stature, infertility, and miscarriages, among others. The latest data published by ECLAMC reports that the overall percentage of malformations is 2.7% and in Ecuador, this percentage is 1.4% \[[@B9]\]. It has been reported that numerical and structural chromosomal abnormalities produce about 4--28% of all mental retardation cases. The severity of mental retardation and the presence of congenital anomalies in these cases increase the diagnostic significance of chromosome abnormalities \[[@B10]\]. Regarding mental retardation, it has been reported that numerical anomalies affect autosomes (6.5%) more frequently than sex chromosomes (0.4%). Also, numerical autosomal anomalies are mostly detected in individuals with more severe mental retardation \[[@B11]\]. Because of this, chromosome analysis of individuals with one or more clinical manifestations related to mental development has been a highly important consideration in the making of the present registry of disabilities in Ecuador. Trisomy 21 is the most common aneuploid condition appearing in approximately 1 out of every 800 to 1,000 live births \[[@B12]\]. According to the Latin-American Collaborative Study of Congenital Malformations ECLAMC (1982--2001), its incidence in Latin American countries like Chile is of 2.2 in every 1,000 newborns while, in Colombia, the condition appears in 15 out of every 10,000 \[[@B5]\]. This Trisomy is also the most frequent autosomal alteration found in our registry with 674 (78.19%) cases. Other chromosomal variants of chromosome 21 were found in less percentage ([Table 1](#tab1){ref-type="table"}). Additionally, Down syndrome mosaicism was present in 10% of the affected cases, a percentage remarkably high in comparison to the reported percentage of 2--4% \[[@B12]\]. This could be explained by the altitude at which Quito and peripheral towns are geographically located since these are places where most of our samples come from \[[@B13]\]. In fact, the ECLAMC showed higher frequencies of birth defects in populations living in high altitudes than the populations at sea level. Nonetheless, there are other factors that could contribute to the etiology of congenital anomalies in these regions \[[@B14]--[@B16]\]. The teratogenicity of hypoxia in mammals was demonstrated in an experiment in 1952 where pregnant mice placed in a low-pressure chamber with reduced oxygen tension gave birth to progeny with birth defects such as anencephaly, cleft palate, and cryptorchidism, among others \[[@B17]\]. Additionally, authors have produced trisomic and triploid embryos by mating hamster females and submitting them to low-pressure atmosphere and hypoxic conditions \[[@B18]\]. The association between congenital anomalies and high altitude has been noted in a number of studies that refer to craniosynostosis, cleft lip, congenital heart disease, neural tube defects, and so forth \[[@B16]\]. Also, studies in South America have concluded that high altitude in Ecuador is associated not only to the occurrence of low birth weight and intrauterine growth retardation regardless of socioeconomic status \[[@B19]\], but it is also a risk factor in the development of microtia and cleft palate \[[@B20]--[@B22]\]. In this study, we show that Down syndrome mosaicism is present in an unusually high percentage in the Andean zones of Ecuador. Although other variables such as maternal age and ethnicity should be addressed, we suggest that high altitude may also be related to this uncommon incidence as an epigenetic factor yet to be fully studied. In Ecuador, the incidence found is 1 of every 526 live births, which is a remarkable fact about the chromosomal constitution of our population \[[@B1]\]. This syndrome displays some developmental abnormalities and clinical characteristics that are normally observed with aging \[[@B23]\] including craniofacial dysmorphy, cardiovascular defects (40 to 50% incidence of congenital heart disease) \[[@B24]\], and learning disabilities \[[@B25]\]. Additionally, those affected present a higher incidence of leukemia (10--20 fold) \[[@B26]\]. Because of its prevalence and clinical importance, Down syndrome has a special relevance in medicine practice and in human biology. Therefore, its chromosomal characterization will offer a better knowledge of the evolution and the prognosis of the affected individuals besides guaranteeing the proper genetic counseling of couples at risk and the population in general. In Ecuador and other countries, there is an absence of basic information regarding individuals with Down syndrome. Thus, some authors highlight the importance of developing a Down syndrome registry, research database, and biobank that can be available to the affected individuals, families, medical care providers, government, and funding sources in order to promote and facilitate the research that focuses on this condition \[[@B27]\]. Although less common, the same attention is needed for other autosomal abnormalities found in our registry such as Trisomy 13 (1.74%) and Trisomy 18 (2.32%), as partial Trisomy and monosomy. The registry also found some interesting autosomal abnormalities such as isochromosomes of the 21 pair and a translocation between chromosomes 2 and 8.

In relation to sex chromosome abnormalities, Turner syndrome is the most frequent alteration found in our registry with a percentage of 77.7. This syndrome is one of the most frequent genetic disorders and affects 1 out of every 2,500 live female births. The main clinical features of Turner syndrome are short stature, low hair implantation, ovarian dysgenesis accompanied by estrogen deficit, otitis, thyroid dysfunction, hypertension, high risk of cardiovascular mortality, and other abnormalities of different levels of severity \[[@B28], [@B29]\]. We found one case of mosaicism with 46,XY/45,X karyotype belonging to a girl that had primary amenorrhea, uterus, and ovaries infertile. Published data has shown that the presence of Y-chromosome material in patients with Turner syndrome represents a risk factor for the development of gonadoblastoma. Y-chromosome mosaicism is observed in 5% of Turner patients; thus, the detection of this chromosome by cytogenetic or molecular means is very valuable \[[@B30]\]. Also, our registry shows a 6% of Klinefelter syndrome cases and fewer percentages of other sex chromosome anomalies ([Table 2](#tab2){ref-type="table"}). Additionally, the Yqh+ polymorphism was found in 12% of men ([Table 3](#tab3){ref-type="table"}), and there were 134 cases that showed chromosomal fragility. The early diagnostic of chromosome abnormalities is essential for guaranteeing an adequate treatment and management of the individuals with the purpose of having the best possible social integration. We consider that it is fundamental to have a National Registry in Ecuador that incorporates a broad range of conditions, including chromosomal abnormalities and findings. This knowledge can be invaluable for the elaboration of appropriate courses of action that promote genetics studies and prenatal diagnosis in the Ecuadorian population.

5. Strengths {#sec5}
============

PopulationThe Ecuadorian population offers unique characteristics that favor the study of gene-environment interactions. Features such as ethnic diversity, geographic location at high altitude, environmental diversity, socioeconomic differences, and poor control of exposure to toxic compounds make of our population a very interesting and novel source of information.

InformationCytogenetic findings in the Ecuadorian population such as the ones presented in this paper have not been published previously elsewhere. Thus, the information offered shows noteworthy data and tendencies.

6. Pitfalls {#sec6}
===========

SampleThe data is based on cases that have generally been referred to the institute by primary care centers where the individuals have been given medical attention because of suspicion or evidence of a medical condition of genetic origin. Therefore, this is not a random sample of the population.

VariablesAlthough it isn\'t one of the objectives of the present paper, our study falls short on showing the association of the cytogenetic findings with other variables such as maternal age, socioeconomic status, and ethnicity.

###### 

Chromosomal autosomopathies in the registry.

                            Number   \%
  ------------------------- -------- -------
  Trisomy 9 (mosaic)        2        0.2
  Trisomy 13                14       1.6
   Trisomy 13 (mosaic)      1        0.1
  Trisomy 18                19       2.2
   Trisomy 18 (mosaic)      1        0.1
  Trisomy 19                2        0.2
   Trisomy 19 (mosaic)      1        0.1
  Trisomy 21                         
   Free trisomy             674      78.6
   Mosaic                   91       10.6
   Isochromosome            5        0.6
   Translocation            14       1.6
   Translocation (mosaic)   1        0.1
  Trisomy 22                1        0.1
  Partial trisomy                    
   4p+                      2        0.2
   7p+                      1        0.1
   9p+                      1        0.1
   14p+                     3        0.3
   15p+                     3        0.3
   19p+                     2        0.2
   19q+                     1        0.1
   21q+                     1        0.1
   22p+                     2        0.2
  Partial monosomy                   
   5p−                      4        0.5
   12p−                     1        0.1
   17q−                     1        0.1
   13q−                     3        0.3
   18p−                     1        0.1
  Isochromosome 17          1        0.1
  Ring chromosome 1         1        0.1
  Ring chromosome 9         1        0.1
  Ring chromosome 15        1        0.1
  inv (9) mosaic            1        0.1
  Add (8) (p23)             1        0.1
                                     
  Total                     858      100.0

###### 

Chromosomal gonosomopathies in the registry.

                                  Number   \%
  ------------------------------- -------- -------
  Turner syndrome                          
   Monosomy                       132      40.1
   Mosaic                         109      33.1
   Isochromosome                  6        1.8
   Isochromosome (mosaic)         8        2.4
   Ring (mosaic)                  1        0.3
  Trisomy X                       3        0.9
   Mosaic                         3        0.9
  Fra (X) (q27.3)                 6        1.8
  Klinefelter syndrome            17       5.2
   Mosaic                         4        1.2
  47,XYY                          7        2.1
  48,XXYY                         4        1.2
  49,XXXXY                        1        0.3
  Disorders of sex development             
   Female pseudohermaphroditism   6        1.8
   Male pseudohermaphroditism     17       5.2
   Mixed gonadal dysgenesis       2        0.6
   Pure gonadal dysgenesis        1        0.3
   Ambiguous genitalia            2        0.6
                                           
  Total                           329      100.0

###### 

Translocations and variants in the registry.

  Translocations   Number   Translocations   Number   Variants and polymorphisms   Number
  ---------------- -------- ---------------- -------- ---------------------------- --------
  t(1;20)          1        t(6;7)           2        1qh+                         2
  t(2;8)           1        t(7;10)          1        9qh+                         6
  t(2;12)          2        t(13;14)         3        15ps+                        1
  t(2;18)          2        t(13;15)         2        16qh+                        1
  t(4;11)          3        t(X;8)           3        Yqh+                         23
  t(5;14)          5        t(X;21)          1        Yqh−                         4
                                                                                   
                            Total            26       Total                        37
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